Skip to main content
Fig. 4 | Thrombosis Journal

Fig. 4

From: Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting

Fig. 4

Effect of pre-specified risk factors on the incidence of sVTE and all-cause mortality, treated set. No events occurred in patients with CHF. Odds ratios, based on univariable logistic regression, were calculated for presence versus absence of risk factor; CIs and p values are based on likelihood-ratio statistics. ASA acetylsalicylic acid, CAD coronary artery disease, CHF chronic heart failure, CI confidence interval, NSAIDs non-steroidal anti-inflammatory drugs, sVTE symptomatic venous thromboembolism

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us